Pregled bibliografske jedinice broj: 1134963
Integrative cBioPortal analysis revealed molecular mechanisms that regulate EGFR-PI3K- AKT-mTOR pathway in diffuse gliomas of the brain
Integrative cBioPortal analysis revealed molecular mechanisms that regulate EGFR-PI3K- AKT-mTOR pathway in diffuse gliomas of the brain // Cancers, 13 (2021), 13; 3247, 18 doi:10.3390/cancers13133247 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1134963 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Integrative cBioPortal analysis revealed
molecular mechanisms that regulate EGFR-PI3K-
AKT-mTOR pathway in diffuse gliomas of the
brain
Autori
Brlek, Petar ; Kafka, Anja ; Bukovac, Anja ; Pećina-Šlaus, Nives
Izvornik
Cancers (2072-6694) 13
(2021), 13;
3247, 18
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
astrocytoma ; glioblastoma ; large-scale analysis ; AKT ; CHUK ; GSK3β ; PIK3AP1 ; PTEN ; EGFR ; cBioPortal
Sažetak
Diffuse gliomas are a heterogeneous group of tumors with aggressive biological behavior and a lack of effective treatment methods. Despite new molecular findings, the differences between pathohistological types still require better understanding. In this in silico analysis, we investigated AKT1, AKT2, AKT3, CHUK, GSK3β, EGFR, PTEN, and PIK3AP1 as participants of EGFR-PI3K-AKT-mTOR signaling using data from the publicly available cBioPortal platform. Integrative large-scale analyses investigated changes in copy number aberrations (CNA), methylation, mRNA transcription and protein expression within 751 samples of diffuse astrocytomas, anaplastic astrocytomas and glioblastomas. The study showed a significant percentage of CNA in PTEN (76%), PIK3AP1 and CHUK (75% each), EGFR (74%), AKT2 (39%), AKT1 (32%), AKT3 (19%) and GSK3β (18%) in the total sample. Comprehensive statistical analyses show how genomics and epigenomics affect the expression of examined genes differently across various pathohistological types and grades, suggesting that genes AKT3, CHUK and PTEN behave like tumor suppressors, while AKT1, AKT2, EGFR, and PIK3AP1 show oncogenic behavior and are involved in enhanced activity of the EGFR-PI3K-AKT-mTOR signaling pathway. Our findings contribute to the knowledge of the molecular differences between pathohistological types and ultimately offer the possibility of new treatment targets and personalized therapies in patients with diffuse gliomas.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Interdisciplinarne prirodne znanosti, Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus